News | April 6, 2021

Hach And LuminUltra Partner To Deliver First Rapid Test For SARS-CoV-2 In Wastewater

Loveland, CO. – Hach® (www.hach.com), a global leader in water analysis and LuminUltra (luminultra.com), a global leader in biological diagnostic testing, have partnered to offer the world’s first rapid, on-site testing solution for the detection of SARS-CoV-2 in wastewater. SARS-CoV-2 is the virus that causes COVID-19. The partnership is a direct response to consumer and community need for same-day test results and accessible, cost-efficient solutions.

“Hach’s mission is to ensure water quality for people around the world. When the pandemic hit, Hach immediately looked to see if there was a way that we could help fight the spread. Wastewater-based epidemiology (WBE) was the logical area for us to contribute,” says James Harbridge, Business Development Manager for Hach. “This partnership with LuminUltra enabled us to quickly bring a product to market with the potential to help slow virus spread. We are excited to see how communities, businesses and schools use this solution to make a positive impact on public health.”

Sampling plus quick, onsite test garners rapid results

Since early 2020, we have learned a lot about COVID-19 and the SARS-CoV-2 virus that causes it. But asymptomatic transmission plus gaps in testing and contact tracing have made it difficult to pinpoint the virus and take appropriate protective action against outbreaks. Streamlined sampling and testing protocols make SARS-CoV-2 wastewater testing one of the least-invasive early warning systems available for continued pandemic management.

The Hach® complete SARS-CoV-2 monitoring offering includes our line of composite samplers plus a SARS-CoV-2 onsite testing method by LuminUltra. The onsite method is based on a simple and quick extraction coupled with an easy-to-use laboratory qPCR (quantitative polymerase chain reaction) analyzer, which produces results within a couple of hours.

“We’re proud of our long-standing partnership with Hach and our history of distributing fast and simple solutions to microbiological problems,” says Pat Whalen, CEO of LuminUltra. “In the face of this global pandemic, regular wastewater monitoring gives us a view into the bigger picture of the health of our communities. This non-invasive testing method is a game-changer for effectively managing the pandemic and this partnership between our two organizations makes this surveillance tool more accessible to communities everywhere.”

Immediate community impact

Emerging public health research confirms the ability to detect SARS-CoV-2 almost a week before physical symptoms of COVID-19 through non-invasive wastewater surveillance system monitoring. This testing solution from Hach and LuminUltra is working for community partners.

“Testing for COVID in the wastewater directly onsite has opened up the opportunities for our Health and Human Service Department to make timely decisions that could immediately benefit our community,” says Dawn Cowell, Wastewater Laboratory Supervisor for the City and County of Broomfield, Colorado. “This test has also opened our eyes to the various wastewater testing capabilities that we didn’t even know existed pre-COVID.”

Explore wastewater testing solutions.

About Hach

For nearly a century, Hach has provided innovations to support our customers. Hach gives customers confidence in their water analysis by delivering expert answers, outstanding support, and reliable, easy-to‐use solutions. Hach analytical instruments, services, software and reagents are used to ensure the quality of water in a variety of industries in more than 100 countries globally.

About LuminUltra

LuminUltra is a biotechnology leader with expertise developing tests and reagents for environmental, industrial, and clinical diagnostic monitoring. Customers around the world rely on its technology and production reliability. LuminUltra is on an accelerated growth path, acquiring multiple companies in recent years and forming a vital partnership with private equity firm XPV Water Partners.

Founded in 1995, LuminUltra is a molecular biology diagnostic testing company headquartered in Canada with operations in 6 countries. It is widely recognized globally as a leader in developing tests and reagents for environmental, industrial, and diagnostic monitoring applications and is a key supplier of COVID-19 diagnostic testing reagents to the Government of Canada.

Dozens of Fortune 500 customers across more than 80 countries trust LuminUltra’s technology, production reliability and history of customer service excellence to deliver their essential services in a safe state.

Source: LuminUltra Technologies Ltd.